Celanese Corporation (NYSE:CE | CE Price Prediction) has staged a sharp recovery in 2026, gaining 35.77% year-to-date. The stock’s one-week gain stands at 9.15%, though shares are up just 8.43% over the past year…
Atlassian (NASDAQ:TEAM | TEAM Price Prediction) has had a punishing stretch. Shares are down 53.47% year to date. Over the past year the stock has fallen 150%, a sharp retreat from a 52-week high…
Delta Air Lines (NYSE:DAL | DAL Price Prediction) has had a rough stretch heading into mid-March. Shares are down 2.31% over the past week, off 16.62% over the past month and down 16.09% year-to-date.…
Occidental Petroleum (NYSE:OXY | OXY Price Prediction) has been on a tear with shares up a 35% year-to-date. Over the trailing twelve months, OXY has gained 25%. The Street’s consensus price target sits at…
Micron Technology (NASDAQ:MU | MU Price Prediction) has been one of the market’s most electrifying performers over the past year. Shares are up 323% over the past 12 months and have gained 28% year-to-date.…
Alcoa Corp. (NYSE:AA | AA Price Prediction), the largest U.S.-based aluminum company, has been a materials sector standout this year with shares up 15% YTD including nearly 12% over the past five trading sessions.…
Oracle (NYSE:ORCL | ORCL Price Prediction) is trading around $165 after a bruising 23% year-to-date pullback from its December close, even as the business just delivered its strongest quarter in over a decade. The…
Oracle Corporation (NYSE:ORCL | ORCL Price Prediction) stock is up over 10% in premarket trading on Wednesday after the company delivered a fiscal Q3 2026 earnings report that put to rest several lingering investor…
Two analyst target raises landed Wednesday morning after solid quarterly results from an oil and gas producer and a grocery distributor. BMO Capital lifted its price target on Matador Resources (NYSE:MTDR | MTDR Price…
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies (NYSE:A | A Price Prediction) while trimming its price target on Icon PLC…
Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector’s fundamentals remain intact, even as broader market volatility has dragged down some of the industry’s…
Oppenheimer initiated coverage of Ocugen (NASDAQ:OCGN) with an Outperform rating and a $10 price target on Wednesday, positioning the clinical-stage gene therapy company as an emerging leader in blinding ocular disorders. The call arrives…
KeyBanc Capital Markets trimmed its price target on AeroVironment (NASDAQ:AVAV | AVAV Price Prediction) to $295 from $330 following the company’s fiscal third-quarter 2026 earnings report, while maintaining an Overweight rating on the shares.…
Stifel analyst Steven Wieczynski cut his price target on Carnival Corporation & plc (NYSE:CCL | CCL Price Prediction) to $35 from $40 on Wednesday, while maintaining a Buy rating on the stock. The revision…
Keefe Bruyette trimmed price targets on two bitcoin-mining-turned-HPC infrastructure companies Wednesday, citing higher spending, reduced hash prices, and the imminent exit from bitcoin mining for both firms. Despite the cuts, the firm kept Outperform…
Goldman Sachs trimmed its price target on Kohl’s Corporation (NYSE:KSS | KSS Price Prediction) to $13 from $15 on Tuesday, maintaining its Sell rating after the department store chain reported what the firm characterized…
Barclays is pushing back against the narrative that artificial intelligence poses an existential threat to insurance brokers, upgrading two of the sector’s largest names while trimming its price target on a third. The bank…
As structural macro shifts replace short-term geopolitical headlines, Warren Buffett’s long-held philosophy on resource-backed investing is facing a real-time examination. So far, his playbook is holding up. Buffett has argued for decades that during…
Three consumer stocks are drawing fresh analyst attention this week as earnings season approaches. Barclays raised its price target on Five Below (NASDAQ:FIVE | FIVE Price Prediction) ahead of its report next week, while…
Wall Street is drawing fresh lines across the large-cap biopharma landscape. Jefferies initiated coverage on Gilead Sciences Inc. (NASDAQ:GILD | GILD Price Prediction) with a Buy rating and a $180 price target, while assigning…
